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Summary 
Non-polar constituents were extracted from Viscum album with hexane, by Soxhlet 
extraction. The extract was analysed by gas chromatography – mass spectrometry, and 
the following fatty acids, methyl esters and triterpenes were identified: methyl 
palmitate, palmitic acid, linoleic acid, linolenic acid, β – amyrin, lupenone, β – amyrin 
acetate and lupeol acetate.  
 
The neutral fraction of Viscum album was extracted through several steps, and 
separated by column chromatography. At least two cyclic peptides were detected by TLC 
protosite reaction with ninhydrin. We identified the cyclic peptide viscumamide and 
found a possible molecular weight for an unidentified cyclic peptide, by DART mass 
spectrometry.  
 
The fractions containing the unidentified cyclic peptide was purified by preparative TLC, 
and analysed by NMR spectroscopy. The analysis showed the presence of the amino 
leucine and an aromatic moiety. The complete structure of this compound could not be 
elucidated because of too many impurities in the sample. 
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1 Introduction 
 
Aim of the Study 
 
Mistletoe has been used in folk medicine since ancient times. Today it is applied as a 
remedy for a broad spectrum of different diseases, such as epilepsy, diabetes, 
hypertension, arthrosis and last but not least, cancer. Modern research clearly indicates 
that components in mistletoe may be valuable in medicine, but good clinical research is 
still lacking. 
 
There are still doubts about which of the constituents contributes to the beneficial 
effects of mistletoe extracts. Research has for the most part focused on polar, water-
soluble components of mistletoe, while non-polar and medium-polar substances have 
been mostly overlooked. We wanted to investigate non-polar constituents in European 
mistletoe (Viscum album L.) Previous research has claimed that there is an variation of 
these components in mistletoe.  
 
An interesting cyclopeptide, viscumamide has been isolated from Korean mistletoe, 
Viscum album var. colaratum, but its pharmacological properties have not yet been fully 
investigated. We wanted to isolate this compound from European mistletoe, and also try 
to identify undiscovered cyclic peptides.  
 
Mistletoe – the Historical Plant 
 
Mistletoe belongs to the families Loranthaceae and Viscaceae, which both share the 
same order Santales, and are closely related. The Viscaceae family have several hundred 
species worldwide, which are divided into seven genera (Arceuthobium, 
Dendrophthora, Ginalloa, Korthalsella, Notothiox, Phodadendron and Viscum). This 
family of parasitic plants is mostly found in tropical areas. 
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The European (Viscum album) white berry mistletoe belongs to the family Loranthaceae. 
It is a small evergreen shrub with linear, lance - shaped leathery leaves, which lasts for 
many seasons. Viscum album is a semi-parasitic plant, growing on different host trees 
and never touching the ground. Birds, feeding of the berries, spread it from tree to tree. 
The plant grows yellowish-green flowers, which develop white translucent berries in the 
late fall and early winter (Büssing, 2000).   
 
 
 
 
Figure 1. 2.1 The European white berry mistletoe (Viscum album)  
 
There are three subspecies of Viscum album in Europe- album, abietis and austriacum. 
They can be found in temperate areas of Europe, Asia and Northern Africa. Another 
subspecies – colaratum grows in China and Japan (Büssing, 2000). 
The Celtic Druids considered mistletoe sacred and representing everlasting life. Unlike 
other plants mistletoe doesn’t follow a 12 months vegetation period, never touches the 
earth, and in the dead of winter when its host tree is bare, this “magic” plant is still green 
and flourishing. The Druids attributed miraculous powers to the plant and believed it 
was a cure for all things (Bowman, 1990) 
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Figure 1.2.2: Romantic picture of Celtic Druids chopping mistletoe of an oak, on which it rarely grows 
(http://www.smk.be/compendium/pdf/mistletoe.pdf) 
 
 
Some of mistletoe’s “magical” powers have endured and even today it is a symbol of 
fertility and good luck. In some European countries and North America the tradition of 
kissing under branches of mistletoe during Christmas, is still popular. The tradition is 
interpreted as a prediction of marriage and a long and happy life.  
 
During the Middle ages people believed that hanging mistletoe from the ceilings would 
keep away evil spirits, and prevent witches and ghosts from entering the houses or 
stables. It has often been carried to battle as a symbol of strength and protection. The 
evergreen condition of the plant associates it with immortality, and the parasitism gives 
it powers to draw tribute from the host (Büssing, 2000). 
 
Mistletoe also appears in the ancient Edda from Noridc mythology. This collection of 
ancient Viking poems tells about how the evil Loki kills Balder, the favourite son of Odin 
(the chief God in Norse paganism), with a spear made of mistletoe. Frigg, Odin’s wife and 
the goddess of love and beauty, had put all objects and beings under an oath not to harm 
her son Balder, but neglected the mistletoe, which seemed unimportant to her. Loki then 
kills Balder with a twig of mistletoe shot by his blind brother Hödur, and Balder is sent 
to the realm of the dead. The Edda describes the hopes for Balder’s return of those 
remaining behind, although this will not happen until the old world has come to an end. 
Then and a new world will rise, where all evil has vanished. This legend may have had 
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its origin from Asia or other parts of Europe, because Viscum album is rarely found in 
northern Scandinavia or Iceland, where the Edda was written (Büssing, 2000). 
 
1.1  The Historical Uses of Mistletoe in Europe 
 
The use of mistletoe in Europe can be traced all the way back to the ancient Greeks. It 
has been recorded that Hippocrates (460-377 BC) used mistletoe to treat diseases of the 
spleen and complaints associated with menstruation. The Platonist Celsus reported that 
mistletoe was used to treat swellings or tumours, around 150 AD. Later in the 1st 
century AD, the Druids used it, as a cure for every illness or “all-heal”, as an antidote for 
poisons and to treat infertility (Büssing, 2000). 
 
In the Middle Ages mistletoe was used for epilepsy. This use was based on the fact that 
mistletoe never falls to the ground. The plant has been used as a remedy for this 
condition up until the 18th century (Büssing, 2000). 
 
During the 12th century the abbess and composer Hildegard von Bingen, described the 
use of mistletoe in treatment of diseases of the liver and spleen. In the 15th century 
rosaries made from mistletoe were popular, and it was believed that wearing them 
could prevent disease. During the 16th century mistletoe was applied for many 
conditions in Europe, including diseases of the kidney and spleen, ulcers, fractured 
bones and the relief of labour-pain. Mistletoe was commonly used as a helminthic drug, 
to treat children infected with intestinal parasites in the 17th century. During this time it 
was also used to treat gout, diseases of the lung and liver, hepatitis, leprosy and labour-
pain. According to the homeopathic materia medica, mistletoe was applied for 
“weakness of the heart”, in the 18th century (Büssing, 2000). 
 
Mistletoe was rejected as a folklore remedy by the end of the 19th century. Scientists 
only accepted a mistletoe containing ointment, Viscin, which has been reported to have 
effects on eczema, ulcers of the feet, burns and for granulating wounds (Büssing, 2000). 
 
In the 20th century an interest for the use of mistletoe in cardiovascular medicine awoke, 
as Gaultier (1907,1910) investigated the effects of Viscum album extracts on blood 
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pressure in man and animals. In the 1920s modern interest for mistletoe began, as 
Rudolf Steiner introduced Viscum album as a possible treatment for cancer. Since the 
early 60s more than 30 clinical studies of mistletoe in cancer treatment have been 
published (Büssing, 2000).  
 
The use of mistletoe is also reported in other parts of the world, like Northern America, 
Japan and Africa.        
 
 
1.2  The Biological and Pharmacological Effects of Mistletoe 
 
Viscum album is one of the most widely used remedies for the unconventional treatment 
of hypertension, arteriosclerosis, arthritis and most importantly cancer (Büssing, 2000). 
  
About 80 randomized clinical studies have been identified, of which 58 have been 
excluded mostly for the lack of prospective trial design. Of the 21 studies included, 13 
provided data on improved survival time, 7 on tumor regression, 16 on improved 
quality of life and 12 reports side effects of mistletoe treatment. Even though most of 
these studies are of poor quality many of them indicate beneficial effects, which should 
encourage further properly designed trials (Horneber et al., 2008). 
 
 
1.2.1    Hypertension 
 
Every year millions of people die of cardiovascular disease. Arterial hypertension is the 
major risk for developing arterial coronary disease, heart failure, cerebral vascular 
disease and renal damage. Established anti-hypertensive drugs may cause a number of 
side effects, and therefore the search for other anti-hypertensive agents continues.   
 
European mistletoe was applied for “weakness of the heart” and oedema during the 18th 
century, and later for arteriosclerosis and hypertension. It is still (1990) listed as a 
vasodilator in Martindale’s Extra Pharmacopoeia. This acceptance of mistletoe as an 
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antihypertensive substance is mainly due to the work of the French physician René 
Gaultier, published in 1907. He successfully treated a patient with pulmonary 
haemorrhage using a medicine containing mistletoe after other treatments had failed. 
After this experience he started a series of experiments. His research showed that 
mistletoe caused a rapid lowering of blood pressure in dogs. He was rewarded with a 
special prize from the Académie de Médecine in Paris for this work (Bowman, 1990). 
 
However, this acceptance of mistletoe as an antihypertensive drug was not universally 
accepted. In 1911 the Belgian physician Felix Dossin stated that mistletoe was not useful 
clinically. He said that it was a dangerous treatment, which often leads to convulsions 
(Bowman, 1990). 
 
Research on mistletoe’s biological properties has mostly focused on its 
immunomodulating activity, and data on possible cardiovascular effects are scarce. In 
2000 Deliorman and co-workers reported that Viscum album affected the diameter of 
coronary blood vessels (Deliorman et al., 2000). 
 
This year M. Radenkovic and co-workers investigated the effects of Viscum album L. 
extracts on arterial blood pressure in rats. They found that the ethanol extract gave a 
significant reduction in the blood pressure at low concentrations. They also showed that 
the antihypertensive effect of the extract might be related to an action on muscarine 
receptors (Radenkovic, 2009). These results supplement other reports on mistletoe in 
antihypertensive treatment (Murray, 1995). It has been suggested that mistletoe 
flavonoids and/or gamma-aminobutyric acid (GABA) isolated from mistletoe is 
responsible for this action (Khwaja, 1990). Even though mistletoe is used in traditional 
phytotherapy for the treatment of hypertension, established medicine still has to 
confirm this activity and clinical trials must be conducted.  
 
 
1.2.2   Diabetes 
 
In Nigerian folk medicine extracts of mistletoe were used to treat diabetes mellitus 
(Büssing, 2000). Research showed that aqueous extracts from two African mistletoe 
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species decreased the serum glucose levels in both non-diabetic and diabetic rats 
(Obatomi, et al., 1994). Similarly, Swanson and Flat reported that an extract from Viscum 
album, supplied as 6,25% by weight of the diet, for 9 streptococin diabetic mice gave a 
relief of polydipsia, hyperphagia and loss of body weight, while glucose and insulin 
plasma levels remained unchanged (Swanston-Flatt et al., 1989). Further, in 1999 Gray 
and Flatt showed that clonal pancreatic B-cells was stimulated to secrete insulin by an 
aqueous extract of dried Viscum album. The treatments require further evaluation (Gray 
and Flatt, 1999). 
 
 
1.2.3   Arthrosis 
 
Plenosol, an aqueosus extract of Viscum album is being used as an alternative treatment 
for arthrosis and/or arthritis of several joints. Research showed that patients 
experienced release from severe pain, increased motility and improved endurance of the 
affected joints, after application of the drug. The side effects reported were 
inflammatory local reactions, slight increase of body temperature, swelling of local 
lymph nodes, night-sweating, headache, and exhaustion. The mode of action is still not 
clear. Most of the research done on Plenosol is of poor quality, and further studies are 
needed (Büssing, 2000). 
 
Viscum album var. colatrum has been used in traditional Chinese medicine to treat 
inflammatory diseases. In 2006 Hwang and co-workers reported that elevation of 
cellular cAMP through inhibition of PDE (phosphodiesterase) is associated with an 
inhibition of inflammatory responses in human neutrophils. The pathogenesis of 
rheumatoid arthritis, chronic obstructive pulmonary disease and other inflammatory 
diseases, are closely connected to neutrophils. Tests have demonstrated that viscolin, 
which is isolated from Viscum album var. colatrum, is a potent inhibitor of PDE. This 
indicates that viscolin might be a useful treatment for these indications (Hwang et al., 
2006). 
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1.2.4   Cancer 
 
In the 1920’s Rudolf Steiner introduced mistletoe as a possible treatment for cancer. 
Mistletoe is one of the oldest cancer treatments reported, and is still one of the most 
used in some European countries.  Only the European white-berried mistletoe Viscum 
album is used in cancer therapy (Legnani, 2008).  
 
Viscum album extracts for this purpose are marketed under different brand names, such 
as Iscador, Eurixor, Helixor, Isorel, Iscucin, Plenosol and Abnoba viscum. Some of them 
are sold and marketed under more than one name. In the USA none of them are available 
commercially. Mistletoe extracts are normally administered by subcutaneous injection. 
Other routes of administration like oral, intrapleural and intravenous have also been 
used. (Mistletoe Extracts - Health Proffesionals Version) 
 
Extracts derived from mistletoe have been shown to kill cancer cells in vitro, and to 
stimulate immune system cells both in vitro and in vivo.(Mistletoe Extracts - Health 
Proffesionals Version) 
 
 Since the 1980s many laboratory and in vitro tests have been conducted on the active 
constituents in mistletoe. Especially viscotoxins, lectins and polysaccharides have been 
investigated. The following effects have been explained as a combined action of these 
constituents: 
 
1) Cytotoxity in tumour cell cultures 
2) Stimulation of lymphocytic proliferation 
3) Increase in the number and activity of neutrophils 
4) Increase in the number of CD4+ cells in HIV-positive patients 
 
The following therapeutic effects of mistletoe have been observed through clinical 
testing: 
1) General improvement of clinical condition 
2)  Slowing of tumour growth 
3) Reduction in cancer pain 
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4) Improvement of quality of life related to appetite, sleep and general wellbeing 
5) Improvement of mood by anti-depressive action 
6) Reduction of infection by stimulation of the immune system 
7) Improved tolerance of radiotherapy and chemotherapy when applied as a 
therapeutic resource (Legnani, 2008) 
 
The immune-stimulating and cytotoxic effects of mistletoe have both been investigated 
in laboratory and animal studies. The active components, viscotoxins and lectins, have 
been studied as active substances, but research on lectins has been more intensive. 
Purified mistletoe lectins (ML) have shown cytotoxic effects and stimulating effects on 
the immune system. Many of mistletoe’s biological effects may be caused by the lectin 
ML-I, or viscumin. Until now four different lectins and a chitin-binding agglutinin have 
been isolated. When ML-I was removed from an extract there was a markedly reduced 
cytotoxic and immune-stimulating effect. However it should be noted that the fermented 
extracts of mistletoe contains a very small amount of ML-I.  
 
A great number of clinical studies have investigated the value of mistletoe as a cancer 
treatment. All studies have been performed in Europe, mainly in Germany and Austria. 
These studies have for the most part been published in Germany alone. Iscador, Eurixor, 
Lekitinol and recombinant lectin ML-I are the mistletoe extracts/ products tested. About 
half of the reported studies were controlled and most were randomized clinical trials. 
The endpoint measured was mostly survival, but also other endpoints like tumour 
response, tumour recurrence and quality were used.  
 
In most of the studies mistletoe was found to be therapeutically effective. However, the 
majority of these trials had one or more major weaknesses which reduced the validity of 
the findings. These errors included too small patient groups, large number of patients 
excluded or who could not be evaluated, mistletoe use concerning dosage or 
interruptions, mistletoe use not documented adequately, absence of control patients or 
randomization procedures not fulfilled. Another problem is that these studies are often 
lacking reports on clinical data about previous and current therapies received by the 
patients.  
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Although mistletoe is known to be a toxic plant the reports on side effects have been 
minimal and not life threatening. Soreness, inflammation at injection sites, headache, 
fever and chills are the most common side effects. Severe allergic reaction, including 
anaphylactic shock has occurred in a few cases. Seizures, vomiting and death have been 
reported following ingestion of untreated mistletoe plants and berries. The amount of 
these substances consumed and the species of mistletoe affects the seriousness of the 
toxic effect.  
 
Among complementary and alternative anticancer medicines mistletoe is the most 
widely studied. Many clinical studies have shown that it improves survival and quality of 
life in cancer patients. Reports on mistletoe stimulation of the immune system have also 
been frequent. The major problem is that most of the studies have had one or more 
major weakness that make the validity of the finding questionable. There is also no 
proof to support the notion that the immune-stimulation activity of mistletoe can be 
connected to the improved survival in cancer patients. There are not yet reports on the 
use of mistletoe as a treatment for cancer in children, since all the clinical studies have 
been performed on adults. More evidence is needed before mistletoe can be 
recommended as a treatment for cancer outside the context of well-designed clinical 
trials(Mistletoe Extracts - Health Proffesionals Version).  
 
 
1.3 The Chemical Constituents of Viscum album 
 
Natural factors like sex, local climate, harvesting time, parts and age of plants used and 
host tree, affect the composition of different chemical constituents in mistletoe. Lectins, 
viscotoxins, flavonoids and many other constituents of mistletoe are being investigated 
in clinical studies in cancer treatments and other conditions (Pfüller, 2000). 
Pharmacological studies on Viscum album have focused on polar extracts and their 
water-soluble constituents, such as mistletoe lectins and viscotoxins. (Cebovic et al., 
2008). 
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1.3.1 Mistletoe Lectins 
 
Lectins have complex molecular structures made up of both proteins and carbohydrates. 
They are capable of binding to the surface of different cells (e.g. immune cells) and 
induce biochemical changes in them (Mistletoe Extracts - Health Proffesionals Version). 
They have at least two sugar-combining sites and show specificity for terminal and/or 
subterminal residues. Lectins will thus recognise specific carbohydrate residues and 
bind to them on the cell surface of cytoplasmic, nuclear structures and to components of 
extracellular matrix.  
 
1.3.2 Viscotoxins 
 
Viscotoxins, which are related to thionines, are a group of amphipathic strongly basic 
polypeptides. Samuelsson (1974) and Urech et al. (1995) isolated at least six isomers of 
viscotoxins mainly from Viscum album. They share a similar structure of 46 amino acids 
and are common in plants like corn and wheat among others, and are suggested to be 
protective substances against viruses, bacteria and fungi. Viscotoxins contain 3 to 4 
disulphide bridges and a three-dimensional model of viscotoxin A3 showed that the 
polypeptide is amphipathic and may therefore interact with lipid bilayers. The 
viscotoxins are exceptionally stable substances and they can stay intact under 
denaturating conditions. They also tend to form protein-lipid-complexes and self-
aggregate. Some of their pharmacological and biological properties may be explained by 
the physio-chemical properties of the membrane-permeabilising viscotoxins. However, 
it is not yet clear why amphipathic polypeptides from mistletoe and other plants, which 
are similar structurally, show different biological effects. It has been suggested that the 
cytotoxic potential could change by changing only a few amino acids. The viscotoxins are 
candidates for further investigations due to their outstanding properties and their 
occurrence in many mistletoe preparations (Pfüller, 2000).     
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1.3.3 Flavonoids 
 
Flavonoids are most commonly known for their antioxidant activity. They are found in 
great variety and are widely distributed in nature. Because of their strong ability to 
modify the body’s reaction to allergens, viruses and carcinogens, they have been 
referred to as “nature’s biological response modifiers”. In experiments flavonoids have 
shown anti-allergic, anti-innflammatory, anti-microbial and anti-cancer activity. Interest 
in their preventive role in cancer and cardiovascular disease has increased (Larmo et al., 
2009, Yang et al., 2009).   
 
Since the 1950s a great number of different flavanoids have been isolated from 
mistletoe (Pfüller, 2000). Among these quercetin has evoked most interest. Reports have 
shown that quercetin inhibits angiogenesis through many mechanisms. Results also 
indicate that the flavonoid enhances the anticancer effects of conventional treatment 
(tamoxifen) through anti-angiogenesis.  More data are needed on dose-response, 
potential toxicities and appropriate combinations with other cancer therapies (Sagar et 
al., 2006). 
 
 
1.3.4 Phenylpropanoids 
 
Phenylpropanoids, commonly known as cinnamic acids are related to flavonoids by a 
common biogenetic pathway. The best known phenylpropanoids like caffeic acid, ferulic 
acid and sinapic acid, together with their degradation products, proptocatechuic acid, 
syringic acid, vanilic acid, anisic acid and genestic acid, have been isolated from Viscum 
album (Pfüller, 2000). Cinnamic acid is used in flavours, synthetic indigo, and certain 
pharmaceuticals, though its primary use is in the production of the methyl, ethyl, and 
benzyl esters for the perfume industry. 
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1.3.5   Phytosterols 
 
Beta-sisterol, stigmasterol and their respective glycosides have been isolated from 
Viscum album (Pfüller, 2000). Phytosterols (also called plant sterols) are a group of 
steroid alcohols, phytochemicals naturally occurring in plants. They are white powders 
with mild, characteristic odor, insoluble in water and soluble in alcohols. They have 
many applications, for instance as food additive taken to lower cholesterol, as well as in 
medicine and cosmetics. 
 
 
1.3.6   Triterpenes 
 
Terpenes constitute a large and varied class of hydrocarbons, which are widespread in 
plants. They are classified according to the number of isoprene units CH2=C(CH3)-CH-
CH3, and have the general formula (C5H8)n.  The isoprene units can be linked together as 
linear chains or rings.   
Triterpenes consist of six isoprene units and have the molecular formula C30H48. Unlike 
mono- sequi- and diterpenes they join tail to tail.  
There is a rich content of triterpenes such as β-amyrin, β-amyrin-acetat, betulinic acid, 
oleanolic acid and ursolic acid in Viscum album (Pfüller, 2000). 
 
 
1.3.7   Alkaloids 
 
Alkaloids are naturally occurring chemical compounds containing basic nitrogen atoms. 
They often have pharmacological effects and are used as medications and recreational 
drugs.  
 
Viscum album L. does not contain typical alkaloids in contrast to Viscum album var. 
colaratum and other species.  Hegnauer (1966) has summarised reports on “alkaloid 
like” substances, including phenylethylamine, choline and acetylcholine in Viscum album 
(Pfüller, 2000).  Alkaloid-like substances in Viscum album L. have also been described by 
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Khawa and co-workers, but they have only been defined by the non-specific 
Dragendorff-alkaloid reagent and remain uncharacterized (Khwaja et al., 1986). 
 
Kwaja and co-workers reported that alkaloids from Korean mistletoe inhibited the 
growth of cultured leukemia cells and increased the life span of leukemic mice. Because 
of the extreme lability of these alkaloids, their structures have not yet been defined. It 
has been proposed that the alkaloids are glycoconjugates with proteins and lectins from 
Viscum album (Pfüller, 2000). 
 
 
1.3.8 Fatty acids 
 
Saturated fatty acids isolated from Viscum album are mainly palmitic and arachidic acid. 
Unsaturated fatty acids isolated are mainly oleic and linoleic acids. Reports on the non-
polar constituents of mistletoe are scarce (Deliorman and Orhan, 2006).  
 
 
1.4.9  Other Biologically Active Components 
 
A 5 kDa peptide with cytotoxic and tumour reducing qualities was isolated from Viscum 
album extract by Kuttan and Kuttan. An increased natural killer cell activity (NK-
activity) was reported after administration of the peptide. It has been suggested that the 
immuno-stimulatory qualities of Viscum album extract (Iscador) is mainly attributed to 
this peptide (Kuttan and Kuttan, 1992). 
 
Rhamnogalacturonan extracted from Viscum album showed NK (natural killer)- and 
lymphokine-activated killer (LAK)- activity against Human Cytomegalovirus (HCMV)-
infected cells (Steinmassl and Anderer, 1996). 
 
Induction of interferon-gamma from CD4+ cells and TNF-alpha from monocytes or 
macrophages was reported from an oligosaccharide extracted from Viscum album 
(Pfüller, 2000).  
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An undefined antigen from an extract of Viscum album from pine trees showed cytotxic 
as well as immuno-modulating qualities. The study suggests that the components of 
mistletoe extracts depend on the host tree and the manufacturing process (Stein and 
Berg, 1997). 
 
In mistletoe the lectins amount to only 2% of the total polypeptide and protein content. 
Except for the viscotoxin type of polypeptide there is little information on structure and 
biological properties of other proteins present in the plant. A fraction of polypetides 
with immunomodulating activity was isolated by Kuttan and co-workers, but these 
polypetides have not yet been characterised (Pfüller, 2000). 
 
In 1973 Okumura and Sakurai discovered viscumamide, a new amphiphilic cyclic 
pentapetide. They isolated it from Viscum album var. coloratum and performed chemical 
and structural studies on it (Okumura and Sakurai, 1972). In 1978 Okumura and Sakurai 
successfully synthesised viscumamide and three analogues, by the N-
hydroxysuccinimide ester method, however at a low yield (Sakurai and Okumura, 1979). 
This cyclic peptide has not been described for the European mistletoe yet and until 
recently, there were no reports on biological activity. Two unpublished studies showed 
that viscumamide had pronounced membrane-binding qualities. By using different 
methods Becker and Pfüller observed an interaction between viscumamide and artificial 
membranes (Pfüller, 2000). In 2005 Poojary and Belagalib evaluated three cyclic 
peptides, viscumamide, yannin A and evolidine for antimicrobial and pharmacological 
activties. Viscumamide showed a moderate anti-inflammatory activity and weak anti-
helminthic activity. Evolidine showed better growth inhibition against bacterial strains 
than yunnanin A and viscumamide (Poojary and Belagali, 2005).   
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Figure 1.5.1: The structure of viscumamide, cyclic (L-isoleucyl-L-leucyl-L-isoluecyl-L-leucyl-L-leucyl)  
 
 
As discussed earlier it is indicated that Viscum album extracts have beneficial effects in 
cancer treatment. There are also reports suggesting beneficial effects in the treatment of 
arthrosis. Viscum album extracts role in the treatment of hypertension and 
arteriosclerosis remains unclear due to the lack of convincing studies. Mistletoe lectins 
and viscotoxins are at present the components mainly attributed to be responsible for 
the beneficial effects of Viscum album. Because of the variety of biologically active 
components in mistletoe extracts, scientists have had difficulties in defining the 
component or components, responsible for beneficial effects (Büssing, 2000) . It is 
possible that other uninvestigated components such as viscumamide, could play an 
important part in this “puzzle”. Research has shown that many cyclic peptides have 
unique qualities and a variety of biological effects. In the following chapters 
viscumamide and the interesting group of cyclopeptides will be discussed.  
 
 
1.4   Plant Cyclopeptides 
  
Cyclopeptides may be defined as cyclic compounds, mainly formed by peptide chains. 
The peptide chains consists of 2-37 protein or non-protein amino acids, mainly 
L(levorotatory)-amino acids.(Tan and Zhou, 2006)  
 
The interest for cyclic peptides during the last few decades has led to intensified 
research in this field. In the early 70s it was noticed that women in Congo drank a 
Introduction  
 17 
 
medicinal tea from a local plant to ease childbirth. 25 years later it was discovered that 
the cyclic protein kalata B1 with uterotonic activity, was responsible for this effect.  
Since then a number of cyclic peptides with promising biological effects have been 
identified from bacteria, plants and animals from Africa, South America, Australia and 
Europe. Often research has been done on plants that have been used traditionally in folk 
medicine. A variety of anticancer, antibacterial, anti-malaria, immunosuppressant and 
anti-HIV effects have been observed, among some of the different cyclopeptides (Tan 
and Zhou, 2006). 
 
 
1.4.1   The Unique Qualities of Cyclopeptides 
 
In addition to the wide range of biological activity cycloeptides also show an exceptional 
stability. Most proteins and peptides are synthesized as linear chains of amino acids 
with one free amino-terminus and one free carboxyl-terminus. In the cyclic peptides the 
two ends are linked together producing a circular topology. This property gives the 
cyclopeptides many advantages over linear peptides. When the two ends are joined 
together it makes it almost impossible for digestive enzymes to attack the peptide. This 
causes the cyclopeptides to stay intact through the gastric intestinal track (GIT). In 
medicine many protein-based drugs (e.g. insulin) must be given by injection to avoid 
degradation in the GIT. Now there is research on using cyclic proteins as a framework 
for linear peptides to keep them intact through the GIT.  The cyclic peptide can be 
exposed to boiling and extremes of pH and still maintain structure and function. It has 
also been discovered that the cyclic backbone makes them more biologically active. This 
is probably due to lack of loose ends that makes it harder to strip them away from the 
target receptor. (Craik, 2006) 
 
 
1.4.2   Classification   
 
Plant cyclopeptides have been classified in many different ways, based on structural 
features, plant source and biological effects, size or amino acids sequence. In 2006 Tan 
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and Zhou classified 455 plant cyclopeptides in two classes, 5 sub-classes and 8 types, on 
the basis of structural features and distribution in plant families (Tan and Zhou, 2006) 
.The following passages follow closely their review.  
 
The two main classes divide them into heterocyclic and homocyclic peptides. The 
heterocyclic structures are constituted by both protein- and non-protein amino acids, 
whilst the homocyclic peptides are constituted by protein-amino acids alone. The 
cyclopeptides are divided into 5 sub-classes on the basis of number of rings: 
heteromono-, heterodi-,homomono-, homodi- or heteropolycyclopetides. Finally they 
are grouped into 7 types according to structural features or distribution in plants. The 
two largest types are type I (Cyclopeptide alkaloids) and type VI (Caryophyllaceae-type 
cyclopeptides). Cyclopetides have mainly been found in the following plant families: 
Annonaceae, Caryophyllaceae, Rhamnaceae and Rubiaceae (Tan and Zhou, 2006).  
 
Viscumamide is the only cyclopeptide discovered in the Loranthaceae family.  
 
 
 
Figure 1.6.1 Classification of Cyclopeptides in Plants (Tan and Zhou, 2006) 
 
Viscumamide has not yet been classified according to this system, probably because of 
the little amount of research available. The substance has a homocyclic structure, 
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constituted by protein – amino acids connected together in one single ring. This kind of 
structure would best fit in with the homomonocyclopeptides.  
 
The homomonocyclopeptides are divided into two types: Compositate – type 
cyclopeptides (Type V) and Caryophyllaceae – type cyclopeptides (Type VI). Type V – 
cyclopeptides are halogenated cyclic pentapeptides. There have been isolated 9 Type V 
cyclopeptides, mainly from the Compositae family, where 3 have shown antitumour 
activity (Tan and Zhou, 2006).  
 
Caryophyllaceae-type cyclopeptides are a large group, which include cyclic di-, penta-,  
hexa-, hepta-, octa-, nona-, deca-, undeca-, and dodecapep- tides. They are mainly found 
in the Caryophyllaceae family, but have also been isolated from other plant families. 
During the past half century around 168 Type VI cyclopeptides have been isolated and 
many of them show biological activities, such as cytotoxic, antiplatelet, antimalarial and 
immunomodulating activities (Tan and Zhou, 2006). 
 
 
 
Figure 1.6.2: The structure of an immunomodulating Caryophyllaceae – type cyclopeptide, Curacycline A,  
 
 Because viscumamide does not have any halogenated groups, such as Type V 
(Compositae –type cyclopeptides), it would be safe to say that is most similar to the 
Type’s VI (Caryophyllaceae-type cyclopeptides). Viscumamide has the elemental 
composition of C30H55N5O5 and a molecular weight of 565,8. It is a cyclic pentapeptide 
constituted of leucin and isoleucin units. Viscumamdie and three analogs have been 
synthesised by Sakurai and Okumura (Okumura and Sakurai, 1972). 
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Figure 1.6.3: Viscumamide (1a) and three synthetic analogs (1b, 1c and 1d) 
 
 
1.6.3   Chemical and Physical Properties  
 
Caryophyllaceae-type cyclopeptides generally have melting points around 200 ˚C and 
are mostly crystalline structures or powders. They can vary from di- to dodecapeptides 
and mainly consist of protein amino acids. These types of cyclopeptides are soluble in 
water, DMSO, C5H5N, methanol, CHCl3 and some other organic solvents (Tan and Zhou, 
2006). 
 
 
1.4.3   Chemical Detection  
 
Cyclopeptide alkaloids are often detected by Dragendorff’s reagent. This reagent reacts 
with heterocyclic amines to give an orange precipitate. This method however is often 
not specific enough to detect other types of cyclic peptides (Tan and Zhou, 2006). 
Because there has been no special chemical method for detection, cyclopeptides have 
been investigated phytochemically less often. In 2000 a new specific method for 
detecting cyclopeptides in plants was developed by Zhou and Tan. The method induces a 
new thin layer chromatography (TLC) protosite reaction with ninhydrin reagent. Based 
on their behaviour in TLC, cyclopeptides can also be distinguished from peptidic amides. 
Additionally it is a useful method to guide cyclopeptide separation and purification. 
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Since this new method was developed, many new cyclopeptides have been identified 
(Zhou and Tan, 2000). 
 
 
1.4.4   Extraction and Isolation  
 
Caryophyllaceae-type cyclopetides. Plant material is dried, ground and often treated 
directly with methanol or ethanol. The extract is then partitioned with chloroform, ethyl 
acetate or butanol. The fractions are then chromatographed on a silica gel column 
repeatedly (Tan and Zhou, 2006). 
  
 
1.4.5   Structural Elucidation 
 
Chemical, enzymatic and spectral methods have been used to determine structures of 
Caryophyllaceae-type cyclopeptides. Chemical methods normally involve analysis of 
amino acids after hydrolysis. Enzymatic methods involve sequence determination after 
enzymatic hydrolysis. IR, NMR and MS are some of the spectral methods used for 
structure determination (Tan and Zhou, 2006).       
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2 Methods and Materials 
 
2.1 General Methods 
 
 
2.1.1 Preparation of Plant Material 
 
Plant material: dried whole plants (without berries) from Viscum album L.  
 
Equipment: electrical blender, Waring  
 
Procedure: 
Plant material was weighed and ground into fine a fine powder 
 
 
2.1.2 Removal of Water and Solvents 
 
Vacuum evaporation: 
Vacuum evaporation is a method used for efficient and gentle removal of solvents from 
samples. A rotary evaporator, which is often used for this purpose, reduces the pressure 
in a closed system in order to lower the boiling point of the solvent. This allows removal 
of the liquid solvent without excessive heating, which may damage the sample.  The 
rotary evaporator consists of a heated rotating flask, which is kept under vacuum 
through a tube connected to a condenser. Vapour from the solvent goes through the 
connecting tube and condenses in the condenser section. In this study all mixtures were 
evaporated under reduced pressure at 40-45˚ C. 
 
Apparatus: Rotavapor RE 120, Büchi.  
 
Small amounts were evaporated with nitrogen (g) 
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2.1.3 pH Measurement 
 
In this study all pH-values were measured with pH-indicator strips from Merck. 
 
 
2.1.4   Thin Layer Chromatography 
 
Thin layer chromatography (TLC) is a chromatography technique used to separate 
mixtures of different compounds.  The TLC plate, which can be made of glass, plastic or 
aluminium foil, is coated with a thin layer of adsorbent material. This layer, which is also 
known as the stationary phase, is usually made of silica gel, aluminium oxide or 
cellulose.  
 
After application of the sample onto the plate, a solvent, also known as the mobile phase, 
is drawn up the plate via capillary action. Different compounds in the sample travel 
different distances on the plate, depending on the their attraction to the stationary 
phase and the difference in solubility in the mobile phase. The polarity of the 
compounds can then be calculated on the basis of an Rf-value (distance travelled by the 
mobile phase/distance travelled by the compound) 
 
In this study TLC was used to evaluate the separation and purity of the extracted 
components, as well as their polarity. 
 
Procedure: 
TLC plates are spotted at the bottom of the plates with capillary tubes. The plates are 
then put in a closed container, containing a small amount of the solvent – system. The 
plates are removed when the mobile phase reaches approximately one cm from the top. 
Then they are dried and viewed under UV-light before they are sprayed. To activate 
spots the plates are heated in a heating cabinet.   
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Detection methods: 
 
 UV-light 
A UV-light (254 nm) is used to visualize the colourless components in the different 
extracts. Aromatics, alpha- and beta-unsaturated carbonyls and conjugated systems are 
some of the typical groups, which are visualized by using UV-light. When the TLC plates 
are exposed to UV-light the silica gel will fluoresce and organic compounds, which 
absorb UV light, will appear as dark blue spots.  
 
PMA – spray  
PMA (Phosphomolybdic Acid) spray is a good “universal” spray, which is fairly sensitive 
to solutions with low concentrations. Most functional groups will stain, but it will not 
distinguish between differences between them based upon the colour of the spots. Most 
often compounds of interest will appear as a dark green colour, while spots of less 
interest will appear as a light green colour. To activate the stains for visualization it is 
necessary to heat the TLC plate after treatment. 
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2.1.5 Column Chromatography 
 
Column chromatography is a method used to purify individual compounds from 
mixtures of compounds. The column, a glass tube with a tap at the bottom, is filled with 
a slurry, prepared from an eluent and a stationary phase powder, to give an even filling 
without air bubbles. The organic material is put on top of the stationary phase, and 
finally it is topped with a small layer of sand. The sand prevents the organic material 
from being disturbed by the addition of fresh eluent. The eluent slowly passes through 
the stationary phase to advance the organic material. The different components in the 
organic material are retained by the stationary phase differently, thus they travel at 
different speeds through the column. This makes it possible to collect the different 
compounds or fractions. During the process it is normal to change the polarity of the 
eluents gradually, so that the least polar components elute first and are then followed by 
components of increasing polarity. Coloured substances can be seen through the glass 
wall as they travel downwards as moving bands.         
 
Procedure: 
A slurry made from the first mobile phase and alumina, is added to the column. The 
large- scale column contains a glass-wool plug at the bottom to prevent bleeding. The 
sample is then added to the column, and finally a layer of sand on top.  The column is 
eluted with the mobile phases and the fractions are collected.  
 
Mobile phases: 
A: hexane (dead volume) 
B: hexane-benzene (2:1) 
C: hexane-benzene (1:2) 
D: benzene  
E: benzene-ether (2:1) 
F: benzene-ether (1:2) 
G: ether 
H: ether-ethyl acetate (1:1) 
I: ethyl acetate-ethanol (2:1) 
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J: ethyl acetate-ethanol (1:2) 
K: ethanol (x2) 
 
Stationary phase:  Merck aluminium oxide (Al2O3) 90 active basic 
Particle size: 0,063 – 0,200 mm (70 – 230 mesh ASTM) 
Activity level I (= 0% water) 
 
Sand: Merck extra pure sea sand  
 
  
 
2.1.6 Extraction Methods 
2.1.6.1 Liquid-solid Extraction 
Liquid-solid extraction is the process where a solvent with a specific polarity is added to 
a solid. Any compound in the solid, which has similar polarity to the liquid, is extracted 
into the liquid phase and may be separated from the solid by gravity or vacuum 
filtration.  A sequence of solvents with different polarity can be used to separate 
complex mixtures into different fractions.  
 
 
2.1.6.2 Soxhlet Extraction 
 
Soxhlet extraction is a purification or extraction technique developed by Franz von 
Soxhlet in 1879. It is particularly used when the compound is partially soluble in a 
solvent but the impurity is not or vice versa. Soxhlet extraction has many advantages to 
other extraction methods. For one the material to be extracted is continuously exposed 
to clean solvent. It is also possible to adjust the extraction temperature, which gives a 
more efficient extraction process. Additionally, the continuous extraction allows rapid 
solvent recovery and thus markedly reduces the amount of solvent required       
 
The Soxhlet extractor is placed onto a flask containing the solvent, and condenser is 
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attached to the Soxhlet. The solid, or in this case, the plant material is put into a paper 
“tube” placed into the main chamber of the apparatus. The solvent is warmed up to 
reflux and goes up through the distillation arm, before it floods into the main chamber 
with the paper tube. As the solvent slowly fills up the chamber the compound will start 
to dissolve. When the chamber is full it empties through the side arm and the cycle 
repeats. In this way the compound is extracted a little at a time, and the solid impurity 
stays in the thimble.   
 
 
 
 
 
Figure 2.1.1: Schematic representation of a Soxhlet extractor 
1: Stirrer bar 2: Still pot (the still pot should not be overfilled and the volume of solvent in the still 
pot should be 3 to 4 times the volume of the soxhlet chamber) 3: Distillation path 4: Thimble 5: 
Solid 6: Siphon top 7: Siphon exit 8: Expansion adapter 9: Condenser 10: Cooling water in 11: 
Cooling water out 
 (http://en.wikipedia.org/wiki/File:Soxhlet_extractor.svg) 
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2.1.6.3 Liquid-liquid Extraction 
 
Liquid-liquid extraction is a method to separate compounds based on their relative 
solubility in two different immiscible liquids. Water and an organic solvent are usually 
used. The two solvents create two separate phases, and the substances are extracted 
from one phase to another depending on their polarity. The two phases can then be 
separated using a separating funnel.  
 
 
2.1.6.4 Acid-base Extraction 
 
Acid-base extraction is a method using sequential liquid-liquid extractions to purify 
acids and bases from mixtures based on the their chemical properties. The procedure is 
commonly used to free crude extracts from neutral, acidic or basic impurities. The 
mixture or compound is dissolved and poured into a separating funnel. The pH of the 
aqueous phase is adjusted to bring the substances of interest into its required form and 
then added to the separating funnel. The mixture is then shaken and allowed to separate 
before the phase containing the substance or substances of interest is collected. The 
procedure is repeated with this phase adjusted to a different pH-value. 
 
 
2.1.6.5 Digestion 
 
Digestion, or precipitate ageing is a process where a freshly formed precipitate is left 
after boiling a mixture. The impurities are left in the solution, and the digested 
precipitate is purer and easier to wash and filter. This physio-chemical process follows 
the principle of Ostwald ripening. The Ostwald ripening phenomenon describes how 
solids or liquid solutions become inhomogenous structures over time. Energetic factors 
will cause large precipitates to draw material from smaller precipitates, which shrink.  
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2.1.7 Gas Chromatography – Mass Spectrometry  
 
Gas chromatography-mass spectrometry (GCMS) is a method that combines the 
advantages of two techniques: gas chromatography and mass spectrometry. It is a good 
way for analyzing mixtures of compounds. The individual components in the mixture 
are separated by gas chromatography, and characterized by mass spectroscopy. This 
enables both a qualitative and quantitative evaluation of a mixture containing a number 
of components.   
 
Instrumental details and settings: 
Hewlett Packard 5890 II Gas Chromatograph with dual column and flame ionization 
detection (FID) in GC unit and a Hewlett Packard 5972 series, mass sensitive detector 
(MSD) HP S971, run from computer with a delicate HP-Chem laboratory data system.  
GC column: Agilent Technologies INC Catalof 190918-105, HP- Ultra 2.  
50m x 200mm, 0,33 Micron, -60 to 325/3500SN, US6698711H 
The samples were run with an initial temperature 50 °C and initial time 1 min.  
Mass range: 50 m/z  - 100 m/z 
 
Gas Chromatography: 
Gas chromatography (GC) is a chromatography technique used for separating and 
analyzing compounds that can be vaporized without decomposing. GC is used to 
separate the different components of a mixture, or to test the purity of a substance. GC 
can also in some cases be used to identify a certain compound. A carrier gas is used as a 
mobile phase and the stationary phase is a microscopic layer of liquid or polymer, which 
coats the inside of a glass or metal tube, also called the column. In principle gas 
chromatography is similar to column chromatography. The analytes in their gaseous 
form interact with different stationary phases in the column, and each compound elutes 
at a different retention time. By comparing the different retention times each 
component can be analyzed.  
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Mass Spectroscopy: 
Mass spectrometry (MS) is an analytical technique for identifying unknown compounds, 
determining molecular weight, isotopic composition of elements in a molecule, and the 
structure of a compound by analyzing its fragmentation. MS can also be used 
quantitatively to find the concentration of a compound in a sample. 
As the individual compounds elute from the GC column, they enter an electron 
ionization source. In this case an EI (electron impact) source was used.  The EI source 
produces ions by the interaction with energetic electrons and gas phase atoms.  It is 
considered a classical method of analyte ionization, especially when coupled with a gas 
chromatograph. It is routinely used to analyze volatile organic compounds with low 
mass and thermal stability. An EI source gives high levels of fragmentation and is 
considered to represent a “hard” method of ionization.  
When the compounds are ionized they break into large or small fragments with a certain 
mass and charge. The mass to charge ratio (m/z) ratio usually represents the molecular 
mass of the fragment, because most fragments have a charge of + 1. 
 According to their m/z ratio the ions are sorted and separated in a mass analyzer, in 
this case a quadrapole analyzer was used. The ions are then detected and tallied in a 
detector. Finally the results are displayed on a chart or spectrum, where the x-axis 
represents the m/z ratios, and the y-axis represents the signal intensity (abundance) for 
each of the detected fragments. This graph is referred to as a mass spectrum.  
As mentioned earlier the EI Source is a “hard” ionizing technique, and due to this the 
mass spectra will be dominated by fragmentation. The molecular ion M+, which 
represent the molecular weight of the analyte will often undergo fragmentation, and 
sometimes not show up in the mass spectrum. However, because many compounds have 
characteristic fragmentation patterns, this could be a very helpful tool to identify them.  
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2.1.8 DART Mass Spectrometry  
 
Direct analysis in Real Time (DART) Mass Spectrometry uses a new atmospheric 
pressure ion source for the direct analysis of molecules from the surface. It 
instantaneously ionizes gases, liquids and solids at atmospheric pressure, by simply 
placing the sample between the DART ionizing source and the mass spectrometer. There 
is no need for solvent or sample preparation and ionization can take place directly on 
surfaces, such as, tablets, bodily fluids, glass, plant leaves, fruits and vegetables.  
Contradictory to mass spectrometry with an EI Source, DART Mass Spectrometry uses a 
so-called “soft” ionizing technique, which gives a relatively simple mass spectra 
dominated by [M+H]+ -, [M-H] - or M+ - molecules. DART can be used to identify 
substances by giving exact mass measurement and possible elemental compositions. 
 
DART settings: 
Helium velocity: 9,0 1/min 
Gas temperature: 250 C° 
 
MS settings: 
Orifice temperature: 120 C° 
Ion Guide Peak voltage 1500 V 
Detector voltage 2400 V 
Mass range 100 – 1000 m/z 
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2.1.9 NMR Spectroscopy 
 
Nuclear magnetic resonance (NMR) is a physical resonance phenomenon, which occurs 
when the nuclei of certain atoms are immersed in a static magnetic field and exposed to 
a second external magnetic field. Only nuclei that possess a property called spin, 
experience this phenomenon. These nucleons have odd numbers of neutrons.  
 
NMR spectroscopy is a frequently used method to study simple chemical structures by 
one-dimensional techniques. One-dimensional NMR gives information about the number 
and types of functional groups or chemical entities in a molecule. To determine the 
structure of more complicated molecules two-dimensional methods are used.  
Many types of information can be obtained from an NMR spectrum.  
 
NMR spectroscopy takes advantage of the qualities of nuclei with spin properties. The 
1H- isotope and the 13C – isotope are most commonly studied.  
 
 
Chemical shift: 
When a nucleus with an odd number of neutrons is placed in a magnetic field it absorb 
energy at a frequency characteristic of the isotope. For instance different 1H - or 13 C - 
atoms absorb energy at slightly different frequencies. Chemical shift is the frequency of 
the absorption for a nucleus of interest relative to the frequency of the absorption of the 
standard.  
The chemical shift of a nucleus is reported in ppm and given the symbol delta (δ): 
δ = (n - nREF) x106 / nREF 
Proton NMR: 
Proton NMR is the application of nuclear magnetic resonance with respect to the 1H – 
nuclei in the molecule being investigated. It is used to identify hydrogen atoms in 
organic molecules and determine their structures. It is important that hydrogen in the 
solvent does not interfere. Therefore, deuterated solvents are mostly used. Chemical 
shifts range between +12 to -4 ppm for most proton NMR spectra of organic compounds. 
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13C NMR: 
13C NMR is the application of nuclear magnetic resonance with respect to the 13C – nuclei 
in the molecule being investigated. It is used to identify carbon atoms in organic 
molecules and determine their structure.  
This method is used when C-H bonds are lacking, and when distinguishing between 
isomers is difficult based on proton NMR alone. Even though the abundance of 13C is 
only 1,1% it is possible to conduct a NMR experiment. 
The combination of 13C NMR and proton NMR is a powerful tool to in the elucidation of 
molecular structures.  
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2.2 Investigation of Non-polar Constituents in Viscum album  
 
Research has mainly been focused on the polar, water-soluble constituents in mistletoe 
and their biological activities. In this section we wanted to investigate the constituents 
in a non-polar Viscum album extract, by GCMS. 
 
 
2.2.1 Soxhlet Extraction 
 
Non-polar constituents in Viscum album were extracted with hexane, by Soxhlet 
extraction.      
 
Equipment: 
Heating mantle 
Stirrer with magnet 
Flask (500ml) 
Soxhlet column connected to a condenser 
Paper thimble for plant material 
 
Procedure: 
Dried and ground plant material (14g) was placed in a thimble inside the Soxhlet 
column. Hexane (300 ml) was heated until boiling in the flask while stirring. The plant 
material was extracted for approximately four hours. Then the yellow extract was 
removed from the flask, and fresh hexane (300ml) added. The process continued until 
the extract from the plant material was almost colourless. The plant residue after 
extraction was weighed to 12,3 g. Hexane was removed from the extract by vacuum 
evaporation. The yellow oily concentrate was dissolved in a small amount of hexane and 
a sample was prepared for GCMS. 
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2.3 Isolation of Viscumamide from Viscum album  
 
In this section we attempted to extract and isolate the cyclic peptide viscumamide from 
the neutral fraction of Viscum album. The extraction-process has many steps and was 
performed on a large scale, because of an expected low yield of viscumamide. The cyclic 
peptide has previously been isolated from Korean mistletoe, Viscum album var. 
coloratum. The methods of Sakurai and Okumura were followed. (Okumura and Sakurai, 
1972) 
 
 
2.3.1 Extraction with Methanol 
 
Polar- and medium – polar constituents were extracted from Viscum album with 
methanol by, Solid-liquid extraction. This was the fraction we were interested in 
working with since viscumamide is a medium-polar constituent.  
 
Equipment and material: 
Dried and ground plant material   
Erlenmeyer flask (1000 ml) 
Shaker 
Filter paper and filter funnel 
Solvent: methanol  
 
Procedure:  
Ground plant material (1kg) was extracted with ethanol (3L) for approximately 24 
hours. The methanol fraction was filtered with filter paper and a fresh portion of 
methanol (3L) was added to the plant residue. The plant residue was extracted for 
another 24 hours, before it was filtered through filter paper. The extract was shaken the 
whole time to ensured controlled and complete mixing. The plant residue was weighed 
to 718,7 g. The bright green methanol fraction was concentrated under reduced 
pressure. A dark green oily concentrate was left after removal of the solvent.  
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2.3.2 Extraction with Ethyl acetate  
 
Medium-polar constituents were separated from the most polar constituents in the 
methanol extract with ethyl acetate by, liquid-liquid extraction.  
 
Equipment and material: 
Erlenmeyer flask (1000 ml) 
Shaker  
Filter paper and filter funnel 
Solvent: ethyl acetate  
 
Procedure: 
The oily concentrate from the methanol fraction was extracted with ethyl acetate for 
approximately 24 hours. A sticky brown residue formed. The bright green ethyl acetate 
fraction was filtered through filter paper, a fresh portion of ethyl acetate was added to 
the residue, and shaken for another 24 hours. This process was repeated three times. 
Using a shaker ensured controlled and complete mixing of the extract. The sticky brown 
residue was weighed to 160,5 g. Ethyl acetate was removed from the fraction by 
evaporation under reduced pressure. A dark green oily concentrate was left after 
removal of the solvent.  
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2.3.3 Neutral Fraction 
 
To remove organic acids and bases from the neutral compounds in the ethyl acetate 
fraction, acid-base extraction was performed.  
 
Equipment and material: 
pH-strips 
Concentrated HCl (l) 
Na2CO3(s) 
Separating funnel 
Solvents: Ethyl acetate and water 
 
Procedure:  
The oily concentrate from the ethyl acetate fraction was re -dissolved in ethyl acetate 
(35 ml) and added to a separating funnel. Concentrated HCl (l) was diluted with water 
until pH=3, and an aliquot of 50 ml added to the ethyl acetate fraction. The mixture was 
thoroughly shaken and left to separate in the separating funnel. After several days the 
light green acid fraction was removed from the separating funnel.  
 
Na2CO3(s) was diluted with water until pH=9, and an aliquot of 50 ml were added to the 
separating funnel with the dark green ethyl acetate fraction. The mixture was shaken 
thoroughly and left to separate. After several days the light green basic fraction was 
removed from the separating funnel, leaving the neutral ethyl acetate fraction behind. 
The neutral fraction was dark green and contained some lumps. Ethyl acetate was 
removed form the neutral fraction by evaporation under reduced pressure. 
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Figure 2.3.1: Flowchart, extraction of neutral fraction 
 
 
 
2.3.4 Digestion 
 
Digestion with boiling hexane was performed to remove remaining non-polar impurities 
from the neutral fraction.  
 
Equipment and material: 
Flask (500ml) 
Heating mantle  
Stirrer with magnet 
Condenser 
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Filter paper and filter funnel 
Solvent: hexane    
 
Procedure: 
Hexane (150ml) was heated until boiling and allowed to cool a little before it was added 
to the neutral fraction. The mixture was heated again and allowed to boil for 
approximately 30 minutes, while stirring. A dark green residue precipitated from the 
mixture. The residue (17,3g) was filtered with filter paper, washed with hexane and left 
to dry overnight.  
 
 
2.3.5 Column Chromatography of Neutral Fraction 
 
Column chromatography was performed to separate different constituents in the 
neutral fraction. A sample was prepared from the neutral fraction and eluted with 
solvents of increasing polarity. It was expected that viscumamide would elute in one of 
the medium – polar fractions.     
 
Equipment and material: 
Flasks (1000 ml) for the individual fractions 
Glass column with a diameter of 7 cm 
Alumina (25g) for sample 
Sand 
Glass wool 
Alumina (700 g) fro column 
 
Preparation of sample: 
The dark green residue from the digestion with hexane was dissolved in hot methanol 
(100 ml). Alumina was added to the mixture and it was evaporated until dryness under 
reduced pressure.  
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Preparation of column: 
The column was prepared as described in section 2.1.5. The sample prepared from the 
neutral fraction was eluted with 500 ml of each of the mobile phases A-K. The 
constituents in the sample were separated and collected into 11 fractions, and vaporised 
under reduced pressure.   
 
 
2.3.6 TLC Analysis of Fractions 1-11 
 
The 11 fractions from the column chromatography were run on TLC plates with β -
amyrin as reference substance. This was done to identify which of the fractions 
contained medium polar constituents.    
 
Materials: 
Stationary phase: Merck silica gel on glass plate (20 x 20 cm) with fluorescence indicator 
F254. Layer thickness: 0,25 mm 
Mobile phase: Petroleum ether – acetone (8:2) 
 
Procedure: 
Samples from each of the fractions were run on TLC plates, following the procedure 
described in section 2.1.4. The plate was viewed under UV – light and sprayed with PMA, 
before heating.   
 
 
2.3.7 Digestion of Fractions 9 -11 
 
The polar to medium-polar fractions (9-11) were pooled and digested with boiling 
hexane to remove remaining non-polar constituents. The procedure was followed 
according to section 2.3.4.  
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2.3.8 Column Chromatography of Polar to Medium-polar Fractions 
(Precipitate)  
 
A sample from the precipitate was prepared for column chromatography, according to 
section 2.3.5. 
 
Equipment and material: 
Mobile phases:  G-K 
Glass column with a diameter of 3,5 cm 
Flasks (500 ml) for the fractions 
Alumina (10 g) for sample  
Alumina (70g) for column 
Sand 
 
 Procedure: 
The column was prepared as described in section 2.1.5. The sample was eluted with 200 
ml of each of the mobile phases G-K. The constituents in the sample were separated and 
collected into 14 fractions, and vaporised under reduced pressure.   
 
 
2.3.9 TLC Analysis of Fractions 1-14 
The 14 fractions were run on TLC plates with β -amyrin as reference substance. This 
was done to investigate their polarity and purity  
 
Materials: 
Stationary phase: Merck silica gel on glass plate (20 x 20 cm) with fluorescence F254. 
Layer thickness 0,25 mm 
Mobile phase: Petroleum ether – acetone (8:2) 
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Procedure: 
Samples from each of the fractions were run on TLC plates, following the procedure 
described in section 2.1.4. The plate was viewed under UV – light and sprayed with PMA, 
before heating.   
 
 
2.3.10 TLC Protosite Reaction with Ninhydrin 
 
TLC protosite reaction is a specific method for detecting cyclopeptides in plants. 
Ninhydrin, which is a common reagent for amino acids, reacts with free amino groups  
(NH or NH2) to produce a pink or purple compound. Most cyclopeptides cannot react 
with ninhydrin, because there are usually no free amino groups present. The TLC 
protosite reaction solves this problem by hydrolysing the peptide links in the 
cyclopeptide to produce free amino groups. The fractions containing medium-polar 
constituents (5 – 12) were analysed by this method. 
 
Equipment and Material:  
 
Stationary phase: Fluka silica gel on glass plate (5 x 10 cm). 
Layer thickness: 0,25 mm  
Mobile phase: chloroform-methanol (8,5:1,5) 
Concentrated HCl (l) 
Sealed glass vessel 
 
Procedure:  
This procedure follows the methods of Zhou and Tan. (2000). Two identical TLC plates 
(plate 1 and 2) are spotted with samples from fraction 5 -12 (3 samples on each plate), 
and developed with the chloroform-methanol system, following the procedure 
described in section 2.1.4.  
 
After the plates had dried, plate 2 was placed and hung in a sealed glass vessel, 
containing concentrated HCL (1ml). The vessel was placed in an oven (110˚ C) for 1-2 
hours. Plate 2 was then cooled for a few minutes and the HCl volatilized.  
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Plate 1(non-hydrolyzed) and plate 2 (hydrolyzed) were sprayed with 0,2% ninhydrin-
acetone reagent, and heated in a drier for several minutes. This final step was repeated.         
 
  
2.3.11 DART Mass Spectrometry 
 
The fractions giving positive results for the TLC protosite reaction with ninhydrin, were 
analysed by DART mass spectrometry.  
 
Preparation of samples: 
Samples were dissolved in methanol-ethyl acetate (1:1) at 100 micrograms/ml.    
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2.4 Investigation of an Unidentified Cyclic Peptide in Viscum 
album 
 
In this section we wanted to investigate further fraction 8 and 9 from section 2.3.10, 
which indicated the presence of an unidentified cyclic peptide.  
 
 
2.4.1 Preparative TLC 
 
Fraction 8 and 9 were pooled together with fraction 7 and 10. This was done because 
traces of the unidentified compound could also be present in these fractions, and to 
prevent the loss of this material. The constituents in the sample were separated by 
preparative TLC, which is a standard analytical separation method.   
 
Equipment and material: 
 
Stationary phase: Merck preparative silica gel on glass plates (20 x 20 cm) with 
fluorescent. Layer thickness 60,2 mm 
Mobile phase: Chloroform - methanol (9:1) 
 
Figure 3.4.1:Schematic figure of preparative TLC plate, showing the site of the sample application 
(A), the zone recovered by scraping (B), a band of green material (C), and the distance travelled by 
the mobile phase (D). 
Methods and Materials 
 45 
 
Procedure:  
The sample was applied as a long streak approximately one cm above the edge of the 
plate, and then developed with the chloroform – methanol system, following the 
procedure described in section 2.1.4. Two preparative TLC plates were used to separate 
the sample. The plate was divided into zones, which were scraped off. The scraped zones 
were separately eluted with warm ethanol, and the silica gel was filtered under reduced 
pressure. Finally the fractions were vaporized under reduced pressure.  
 
 
2.4.2 NMR Spectroscopy  
 
One of the fractions from the preparative TLC showed some crystallisation, indicating a 
better purity than the other fractions. This fraction was also in the expected area of the 
Rf-values of the cyclic peptide, according to the TLC – protosite reaction with ninhydrin 
(marked zone in figure 2.4.1). A sample was prepared and analysed by NMR 
spectroscopy.  
 
There are no standard protocols to determine the structure of cyclic peptides by NMR. 
Yang and Zou has proposed a strategy for structural elucidation by NMR, which can be 
used as a guide. This involves 1H NMR and 13C NMR in C5D5N, DMSO-d, or CD3OD to 
determine the planar structure of the compound. If one set of sharp 1H and 13C signals 
under suitable conditions can be obtained 2D NMR techniques can be used to determine 
the molecular composition (Tan and Zhou, 2006). 
 
Instrumental settings: 
The NMR experiments (1H, 1H-13C HMBC, 1H-13C HSQC, 1H-1H COSY, 1H-1H TOCSY, 1H-1H 
ROESY, 1H-1H NOESY and 13C (C) APT were obtained at 600.13 and 150.90 MHz for 1H 
and 13C, respectively, on a User Biospin AV-600 MHz instrument equipped with a TCI 1H-
13C/15N CryoProbe. All experiments were recorded at 298K. Chemical shift values were 
set relative to the deuterio-methyl 13C signal and the residual 1H signal of the solvent at δ 
49.0 and δ 3.34 for CD3OD. 
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3 Results and Discussion 
 
3.1 Investigation of Non-polar Constituents in Viscum album 
 
The chromatographic profile of the hexane extract evidenced the presence of 11 
compounds. We attempted to identify them by their fragmentation patterns, and 
searches in a mass spectral library and SBD (Spectral Database for Organic Compounds). 
The 6 first peaks (I-VI) in the gas chromatogram represented fatty acids and fatty acid 
esters, and the last peaks (VIII-XI) represented triterpenoids. Most of these have already 
been found in Viscum album. 
 
 
 
 
 
Figure 3.1.1 Gas chromatogram of hexane extract, where the peaks are numbered I – XI   
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3.1.1 Results from Gas Chromatography Mass Specrometry 
 
Compound I 
 
Abundant peaks appear in the mass spectra (appendix 2) at m/z 55, 74 (base peak), 87 
and 143. The base peak, m/z 74 indicates that a methyl ester is present.  The base peak 
m/z 74 is a McLafferty rearrangement ion, which is used to identify most methyl ester 
derivates of fatty acids. The ions at m/z 87 and 143 of the general formula 
[(CH2nCOOCH3]+, where 87 is the most abundant., are formed by the losses of neutral 
aliphatic radicals .The molecular ion is missing, but methyl esters usually show weak M+ 
ions.  A library search showed that this most likely is methyl palmitate. 
 
 
Figure 3.1.2: Mclafferty rearrangement in methtyl esters 
 (http://w ww.lipidlibrary.co.uk/ms/ms03/index.htm) 
  
 
Compound II 
 
 Abundant peaks appear in the mass spectra (appendix 3) at m/z 60, 73,129, and 
256(M+). The m/z 60 is a typical Mclafferty rearrangement ion for aliphatic carboxylic 
acids. The spectra shows the regular series of fragment ions separated by 14 amu, which 
indicates that no other functional groups are present.  
A library search showed a striking similarity with a standard spectrum of palmitic acid, 
which is one of the most common saturated fatty acids found in animals and plants. 
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Compound III and IV 
 
The mass spectra of compound III and IV (appendix 4 and 5) were similar, indicating 
that they are related to each other. The mass spectrum of compound III gave little 
information, but the abundant peak at m/z 67 (C5H7+) as a result of double bond 
transfer, is characteristic for biunsaturated fatty acids (Wu et al., 2006).  
 
A library search suggested that compound number IV might be linoleic acid. The ions 55, 
67, 81,95,109,123 as a result of cleavage of alpha series, are characteristic for linoleic 
acid. Compound III is probably an isomer, with double bonds located in different 
positions. 
 
 
Compound V 
 
The mass spectrum of compound V (appendix 6) shows similarities to the mass 
spectrum IV, with abundant peaks at m/z 55 and 67, which suggests they are related. 
However, the spectrum of compound IV has 79 m/z  (C6H7+) as the most abundant ion. 
According to Wu Hui-Qin and coworkers, the base peak can determine the degree of 
unsaturation in fatty acids, where m/z 74, 55, 67 and 79 is characteristic for saturated, 
monounsaturated, biunsaturated and polyunsaturated fatty acids respectively (Wu et al., 
2006). Spectrum V also showed a strikingly similarity to a standard spectrum of the 
polyunsaturated fatty acid, linolenic acid (SDBS) 
 
 
Compound VI 
 
The mass spectrum of compound VI (appendix 7) was poor and gave very little 
information. A search in a library and SDBS gave no results. The base peak is at m/z 55 it 
is possible that this is a biunsaturated fatty acid. It is otherwise difficult to say anything 
more about this compound. 
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Compound VII 
 
The mass spectrum of compound VII (appendix 8) shows a typical fragmentation 
pattern of triterpenoids. A library search gave no result. However, Kolhe and coworkers 
isolated a triterpene, butyrospermenone, which showed a similar fragmentation pattern, 
with a base peak at 69 m/z, in addition to abundant fragments at 409, 207, 311. 
Butyrospermenone has the molecular formula C30H48O, the molecular weight 424, and is 
related to oxo triterpenes, such as β-amyrenone, α-amyrenone and lupenone. It was 
difficult to find more information about this compound (Kolhe et al., 1981).  
 
 
Compound VIII  
 
A library search gave no results for this compound (appendix 9), and a standard 
spectrum was not found in SDBS. However, the abundant ions at m/z 218, 203, 207 and 
189 are typical for the fragmentation of β-amyrin. The spectra also had striking 
similarities with a mass spectrum of a standard sample of β-amyrin, by Liu and co-
workers (figure 3.1.4) (Liu et al., 2009). 
 
 
 
Figure 3.1.3: Mass fragmentation of β – amyrin (http://prr.hec.gov.pk/Chapters/426-9.pdf) 
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Figure 3.1.4: Mass spectra of standard sample of β-amyrin (Liu et al., 2009) 
 
 
Compound IX: 
A library search gave no results for the mass spectrum of compound IX (appendix 10), 
and a standard spectrum was not found in SDBS. However, the abundant peaks at m/z 
424 (M+), 205, 218 and 189 are typical for the fragmentation of lupenone.  
 
 
 
Figure 3.1.5: Mass fragmentation of lupenon (Plumejai and Saifah, 1986) 
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Compound X: 
 
The mass spectrum of compound X (appendix 11) was strikingly similar to a standard 
spectrum of β-amiryn aceate (SDBS). Both the unknown and the standard spectra 
showed abundant peaks at m/z 218 (base peak), 203, 189 and 69. The molecular ion 
(468 m/z) is not visible in the unknown or the standard spectrum.   
 
 
Compound XI 
 
It was difficult to find a standard mass spectra that matched this fragmentation pattern 
well in a library or a database. Judging from the abundant peak at m/z 189 and the 
molecular ion at m/z 468 this is most likely lupeol acetate, or an isomer (appendix 12).  
 
 
Figure 3.1.6: Mass fragmentation of lupeol acetate (http://prr.hec.gov.pk/Chapters/426-9.pdf) 
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Figure 3.1.7: Identified compounds in hexane extract  
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Table 3.1.1 Identified and unidentified compounds detected in hexane extract 
   
 
 
 
 
 
 
 
Compou
nd 
  
Ret. time 
(min.) 
 
Ions (m/z) 
(descending 
intensity) 
 
Mw 
 
Mf 
 
 
I Methyl 
palmitate 
 
26,728 74, 87, 55, 143 270.5 C17H34O2 
II Palmititc acid 
 
27,38 73, 60, 129, 256 256.4 C16H32O2 
III Linoleic acid 
(isomer) 
29,45 67, 55, 81, 95 280.4 C18H32O2 
IV Linoleic acid 
 
30,16 67, 55, 81, 95, 280 280.4 C18H32O2 
V Linolenic acid 
 
30,28 79, 67, 55, 95, 108 278.4 C18H30O2 
VI Unidentified 
fatty acid 
 
30,5 55, 73, 95, 129 - - 
VII Unidentified 
triterpene 
 
44,66 69, 55, 207, 311, 
409 
408 - 
VIII β -amyrin 
 
44,83 218, 203, 55, 69, 
189, 281 
 
426.7 C30H50O 
IX Lupenone 
 
45,3 55, 95, 109, 205, 
189, 424 
 
424.7 C30H48O 
X β - amyrin 
acetate 
 
46,132 218, 203, 55, 69, 
189 
468.8 C32H52O2 
XI Lupeol acetate 46,65 69, 95, 189, 207, 
468 
468.8 C32H52O2 
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3.2   Isolation of Viscumamide from Viscum album 
 
The neutral fraction of Viscum album was extracted through several steps. Column 
chromatography was performed to isolate the cyclic peptide from other constituents in 
the neutral fraction.   
 
 
3.2.1 Column Chromatography of Neutral Fraction   
 
Fraction Eluent Volume (ml) Fraction 
colour 
Solvent Crystals/ 
Precipitation 
1 A 500 - Hexane - 
2 B 500 - Hexane - 
3 C 500 - Hexane ++ 
4 D 500 LY Hexane - 
5 E 500 LY Ethyl acetate - 
6 F 500 LY Ethyl acetate - 
7 G 500 Y Ethyl acetate - 
8 H 500 Y Ethyl acetate - 
9 I 500 BY/G* Methanol + 
10 J 500 BG Methanol - 
11 K 500 LG Methanol - 
 
Table: 3.2.1: Column chromatography of neutral fraction 
L= light colour, B = bright colour, Y = yellow, G = green  
 
It was expected that viscumamide would elute in one of the medium polar fractions. 
Fraction 9, which showed some crystallisation, was analysed by DART spectroscopy. 
However, the MS spectra showed no significant peak in the excepted area for 
Viscumamide. This was most likely because too many other compounds were present in 
the fraction.  
                                                        
* Was presented as a strong coloured band in the column 
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3.2.3 TLC Analysis of Fractions 1-11 
 
TLC analysis of fraction 1-11, from the column chromatography, was performed to get 
an indication of the polarity and purity of the individual fractions. β-amyrin is a non-
polar compound, so we were interested in the fraction below the Rf-value for this 
compound (fraction 9-11).  
  
 
 
Figure 3.2.1 Schematic figure of TLC plate with samples from fraction 1-11 and β - amyrin, after 
spraying with PMA.   
A = application site, B = distance travelled by mobile phase 
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3.2.4 Column Chromatography of Polar to Medium-polar Fractions 
(Precipitate)   
 
To improve the purity of fraction 9 -11, we repeated digestion with boiling hexane 
(section 2.3.7). A sample was prepared from the precipitate, and separated by column 
chromatography into 14 fractions.  
 
 
Fraction Eluent Volume 
(ml) 
Fraction-
colour 
Solvent Crystals  
/Precipitation 
1 G 200 LY Ethyl acetate - 
2 G 50 - Ethyl acetate - 
3 G + H 50 BY Ethyl acetate - 
4 H 150 BY Ethyl acetate + 
5 H 50 Y Ethyl acetate - 
6 H + I 50 Y Ethyl acetate-
ethanol (1:1) 
- 
7 I 50 BY/G * Ethyl acetate- 
methanol (1:1) 
++ 
8 I 50 BG/Y Ethyl acetate-
methanol (1:1) 
- 
9 I 50 BG Ethyl acetate- 
methanol (1:1) 
- 
10 I + J 50 BG Ethyl acetate-
methanol (1:1) 
- 
11 J 50 LG Methanol - 
12 J 100 LG Methanol - 
13 J + K 50 LG Methanol - 
14 K 150 LG Methanol - 
 
Table 3.2.2: Column chromatography of the medium - polar and polar fractions (precipitate) 
L= light colour, B = bright colour, Y = yellow, G = green, 
 
 
                                                        
*  Was presented as a strong coloured band in the column  
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3.2.5 TLC Analysis of Fractions 1-14 
 
TLC analysis of fraction 1-14 was performed to get an indication of the polarity and 
purity of the individual fractions. The analysis showed that fraction 5 -12 contained the 
medium polar constituents we wanted to investigate further.  
 
 
 
Figure 3.2.2: Schematic figure of TLC plate with samples from fraction 1-14 and β-amyrin, after 
spraying with PMA. 
A = application site, B = distance travelled by mobile phase 
 
 
3.2.6 TLC Protosite Reaction with Ninhydrin 
 
Fraction 5-12 was investigated by TLC protosite reaction with ninhydrin, to determine if 
there are cyclic peptides present.  
 
Clear pink/purple spots appeared in the plates with samples from fraction 6,7,8 and 9, 
on the hydrolysed plates. The corresponding non-hydrolysed plates gave no positive 
reaction after spraying with ninhydrin. This gives a strong indication that there are 
cyclic peptides present. Fraction 7, 8 and 9 showed two clearly separated spots on the 
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hydrolysed plate, indicating that there might be more than one cyclic peptide present in 
these fractions.  
 
 
 
 
Figure 3.2.3: Hydrolyzed (left side) and non-hydrolyzed (right side) TLC plates with samples from 
fraction 5-12 after spraying with ninhydrin.  
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Fraction Non-hydrolyzed plate Hydrolyzed plate Rf -value 
6 - Pink spot 0,80 
Pink spot 0,66 7 - 
Purple spot 0,72 
Pink spot 0,61 8 - 
Purple spot 0,67 
Pink spot 0,68 9 - 
Purple spot 0,73 
 
Table 3.2.3: Results from the TLC protosite reaction with ninhydrin, showing the presence of 
pink/purple spots and their corresponding Rf-values. 
 
 
3.2.7 Results from DART Spectroscopy  
 
 
Fraction 6: 
The mass spectrum showed a relatively small peak at m/z 566, which corresponds to 
the molecular mass of viscumamide. There is an excess of other components in this 
sample, judging from the large range of peaks in the mass spectrum,  
 
Fraction 7: 
The mass spectrum showed a relatively strong peak at m/z 566 and had the clearest 
spectrum (figure 3.2.4) A computer program calculated the possible elemental 
compositions of m/z 566 (appendix 14). Among these was the molecular formula 
C30H56N5O5, which corresponds well to the molecular formula of viscumamide, 
C30H55N5O5. The m/z 566 probably represents an M+ H ion. 
 
 Fraction 7 eluted with a strong bright yellow/green band (section 3.2.4), and it seems 
that most of the viscumamide eluted with this bright coloured material. However, there 
are other compounds in this sample, judging from the mass spectra.  
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We attempted to purify this fraction by re-crystallisation with ethanol, as performed by 
Okumara and Sakurai, but it was unsuccessful. The fraction contained some crystals but 
they were brown and not needle shaped as described in literature (Okumura and 
Sakurai, 1972).  
 
 
 
Figure 3.2.4: MS spectrum from fraction 7 at the time of maximum for m/z 566. 
 
 
Fraction 8: 
The mass spectrum showed a small 566 peak, and an excess of other components. A 
small but interesting peak at m/z 717 m/z was observed in this fraction. It is possible 
that the peak corresponds to an unidentified cyclic peptide. Results from the TLC 
protosite reaction indicated that there were two individual cyclic peptides present in 
fraction 7, 8 and 9 or possibly two different isomers. 
 
 
Fraction 9: 
The mass spectrum showed a very small peak at m/z 566. The m/z 717 peak is most 
abundant in this fraction and gives the clearest spectrum (appendix 16).  
 
As we can see from table 3.2.4 m/z 566 is found in all four fractions, but mainly in 
fraction 7. The intensity decreases from fraction 8 to 9.   
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Sample Time of maximum for 566 m/z (min) Intensity x104 
6 1,2 520 
7 2,3 840 
8 3,2 180 
9 4,2 80 
 
Table 3.2.4: The distribution of m/z 566 in sample 6,7,8 and 9 at the time of maximum 
 
Traces of the m/z 717 is also found in all four fraction but mainly in fraction 9, and with 
an increasing intensity from fraction 6 to 9 (table 3.2.5)  
 
Sample Time of maximum for 717 m/z (min) Intensity x104 
6 1,3 10 
7 2,4 20 
8 3,4 36 
9 4,5 92 
    
Table 3.2.5: The distribution of m/z 717 in sample 6,7,8 and 9 at time of maximum 
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3.3 Investigation of an Unidentified Cyclic Peptide in Viscum 
album 
 
Results from the TLC protosite reaction with ninhydrin (section 3.2.6) and DART mass 
spectrometry (section 3.2.7) indicated the presence of an unidentified cyclic peptide in 
fraction 8 and 9. The fractions were purified by preparative TLC and analysed by NMR 
spectroscopy.  
 
 
3.2.1 Results from NMR Spectroscopy 
 
The 1D NMR spectrum showed signals in the aliphatic region and the aromatic region.   
The aliphatic part is most likely leucine, because of characteristic chemical shift values 
(table 3.3.1). Signals in the aromatic region indicate an aromatic moiety, which is 
symmetrically substituted at C1 and C4 with carbonyl (table 3.3.1). We tried to find out 
how the aromatic part and the aliphatic part are connected together by 2D NMR 
techniques, but it was difficult because of impurities in the sample.  
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Figure 3.3.1: Leucine- part                                                            Figure 3.3.2 Aromatic part                               
 
Aromatic part 
 1H (ppm) 13C (ppm) 
C=O  169.2 
1  133.5 
2 7.75 ddd 0.7, 3.3, 5.6 129.8 
3 7.66 ddd 0.7, 3.3, 5.6 132.4 
4  132,4 
5 7.66 ddd 0.7, 3.3, 5.6  132.4 
6 7.75 ddd 0.7, 3.3, 5.6 129.8 
C=O  169,2 
Leucine -part 
 1H 13C 
C=O  169.2 
1 4.25 t 5.1 68.85 
2 1.71 m
∗
 40.1 
3 1.46 m 24.9 
4 O.97 m 14,3 
5 0.97 m 14.3 
 
Table 3.3.1 NMR results from 1D 1H, 13C, COSEY 2D HMBC and 2D HSQC
                                                        
∗ Due to impurities we could not report the coupling constant 
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Conclusion: 
The non-polar constituents found in Viscum album correspond well with previous 
investigations of mistletoe species, especially concerning the triterpenoids. It could 
indicate that the composition of substances doesn’t vary as much from species to species 
or from host to host as previously suggested. However, there were no records found on 
the detection of linolenic acid and lupenone in Viscum album, so it is possible that there 
are some variations. To determine some of the structures in the non-polar extract 
standard samples could have been used. By comparing mass fragmentation and 
retention time we could have established the identity of these compounds. To 
investigate the full profile of non-polar constituents in Viscum album, extracts with 
different polarities could be used. In this study we only investigated the volatile non-
polar components in Viscum album.   
 
The isolation of the cyclic peptide viscumamide from the neutral fraction of Viscum 
album was attempted. The high content of polysaccharides and other polar substances 
made this very difficult. Even though the extract was thoroughly washed with acidic and 
basic solutions, and repeatedly separated by column chromatography, the cyclic peptide 
was not successfully isolated. The generally low content of cyclic peptides in plants is a 
familiar problem when it comes to isolation and purification. However, we managed to 
detect viscumamide by DART mass spectrometry in some of the neutral fractions. This 
cyclic peptide has previously only been isolated from Korean mistletoe. To isolate 
viscumamide or other cyclic peptides a large amount of plant material must be used and 
good separation techniques.  
 
Additionally an unknown cyclic peptide was detected in the neutral fraction of Viscum 
album. The TLC protosite reaction with ninhydrin showed that more than one cyclic 
peptide was present in the neutral fraction and results from DART mass spectrometry 
indicated the molecular weight to be 717 g/mol. NMR spectroscopy indicated the 
presence of leucine and aromatic moieties. We could not find out how they are 
connected because of impurities in the sample. With a pure sample the structures of 
cyclic peptides can be determined by NMR, MS and amino acid analysis. It could be 
useful to purify this cyclic peptide with an Amberlite XAD-7 column. This column 
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reversibly adsorbs aromatic compounds, whereas free sugars and other non-aromatic 
compounds are removed by washing with distilled water (Andersen and Francic, 2004)
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List of Chemicals 
 
Substance Formula Purity (%) Brand 
Acetone CH3CH2CH2OH >99,5  Sigma -Aldrich 
β – amyrin C30H50O Not given Koch-Light  
Chloroform CHCl3 99,0 – 99,4  Ridel-de Häen 
Diethyl ether (CH3CH2)2O >99,5 Sigma -Aldrich  
Ethyl acetate C4H8O2 >99,5 Sigma- Aldrich 
Ethanol CH3CH2OH Not given Arcus Kjemi 
Hexane C6H14 >99,0 Sigma-Aldrich  
Hydrochloride 
Acid 
HCl Minimum 37 Ridel-de Häden 
Methanol CH3OH >99,9 Sigma-Aldrich 
Sodium Carbonate Na2CO3 p.a JT Baker 
Ninhydrin C6H4COC(OH)2CO Puriss Fluka 
Petroleum ether Not applicable >95 Riedel-de Häden 
Phosphomolybdic 
Acid (PMA) 
       H3PMo12O40 A.C.S reagent  Sigma-Aldrich 
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